WallStreetZenWallStreetZen

NASDAQ: ME
23andme Holding Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ME

Based on 1 analyst offering 12 month price targets for 23andme Holding Co.
Min Forecast
$0.47-6.93%
Avg Forecast
$0.47-6.93%
Max Forecast
$0.47-6.93%

Should I buy or sell ME stock?

Based on 1 analyst offering ratings for 23andme Holding Co.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ME stock forecasts and price targets.

ME stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-16

1 of 1

Forecast return on equity

Is ME forecast to generate an efficient return?

Forecast return on assets

Is ME forecast to generate an efficient return on assets?

ME revenue forecast

What is ME's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$263.5M+6.26%
ME's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ME revenue growth forecast

How is ME forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
6.26%
Industry
2.43%
Market
13.58%
ME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ME's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ME vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
ME$0.51$0.47-6.93%Hold
SERA$9.79N/AN/A
NOTV$4.70$18.25+288.30%Strong Buy
BDSX$1.25$3.50+180.00%Strong Buy
STIM$3.83$8.00+108.88%Strong Buy
View Top Diagnostic & Research Stocks

23andme Holding Co Stock Forecast FAQ

Is 23andme Holding Co Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ME) stock is to Hold ME stock.

Out of 1 analyst, 0 (0%) are recommending ME as a Strong Buy, 0 (0%) are recommending ME as a Buy, 1 (100%) are recommending ME as a Hold, 0 (0%) are recommending ME as a Sell, and 0 (0%) are recommending ME as a Strong Sell.

If you're new to stock investing, here's how to buy 23andme Holding Co stock.

What is ME's revenue growth forecast for 2025-2025?

(NASDAQ: ME) 23andme Holding Co's forecast annual revenue growth rate of 6.26% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.58%.

23andme Holding Co's revenue in 2024 is $247,987,000.

In 2025, ME is forecast to generate $127,248,533,586 in revenue, with the lowest revenue forecast at $127,248,533,586 and the highest revenue forecast at $127,248,533,586.

What is ME's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: ME) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.14%.

What is ME's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ME price target, the average ME price target is $0.47, with the highest ME stock price forecast at $0.47 and the lowest ME stock price forecast at $0.47.

The Wall Street analyst predicted that 23andme Holding Co's share price could fall to $0.47 by Apr 16, 2025. The average 23andme Holding Co stock price prediction forecasts a potential downside of 6.93% from the current ME share price of $0.51.

What is ME's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: ME) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.